SecBot SecBot
SECBOTREPLAY Home › Report › LFCR

LFCR · Lifecore Biomedical announced a new commercial manufacturing agreement…

Lifecore Biomedical, Inc. · PRESS-RELEASE filed Jun 15, 2026 at 07:05 ET

At the news

BULLISHIMPACT 6/10

PRESS-RELEASE filed Jun 15, 2026 at 07:05 ET

Lifecore Biomedical announced a new commercial manufacturing agreement with an unnamed global pharmaceutical company for an injectable neurology product. This marks the seventh late-stage program win in seven months, signaling strong business development momentum for the CDMO.

  • New agreement with a global pharma company for tech transfer and commercial manufacturing of an injectable suspension product for neurological disorders
  • Seventh late-stage program win in the last seven months
  • Product is a higher-viscosity suspension formulation requiring specialized manufacturing expertise
  • Contract is with an undisclosed global pharmaceutical company (counterparty name not disclosed)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access